• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于兴奋剂控制的促红细胞生成素稳定剂罗沙司他及其可能代谢物在纯种马中的鉴定。

Identification of Hypoxia-inducible factor (HIF) stabilizer roxadustat and its possible metabolites in thoroughbred horses for doping control.

机构信息

Equine Forensic Unit, Central Veterinary Research Laboratory, Dubai, United Arab Emirates.

出版信息

Drug Test Anal. 2021 Jun;13(6):1203-1215. doi: 10.1002/dta.3014. Epub 2021 Feb 23.

DOI:10.1002/dta.3014
PMID:33569900
Abstract

Hypoxia-inducible factor (HIF) stabilizer belongs to a novel class of pharmacologically active substances, which are capable of inducing the endogenous erythropoietic system. The transcriptional activator HIF has been shown to significantly increase blood hemoglobin and is well set for the treatment of anemia resulting from chronic kidney disease. This research work reports a comprehensive study of the most popular HIF stabilizer roxadustat and its metabolites in thoroughbred horse urine after oral administration. The plausible structures of the detected metabolites were postulated using liquid chromatography-high-resolution mass spectrometry. Under the experimental condition 13 metabolites (7 phase I, 1 phase II, and 5 conjugates of phase I metabolism) were positively detected (M1-M13). The major phase I metabolites identified were formed by hydroxylation. Dealkylated and hydrolyzed phase I metabolites were also observed in this study. In phase II, a glucuronic acid conjugate of roxadustat was detected as the major metabolite. The sulfonic acid conjugates were observed to be formed from phase I metabolites. The characterized in vivo metabolites can potentially serve as target analytes for doping control analysis; hence, the result is an important tool for assessing its use and abuse in competitive sport.

摘要

缺氧诱导因子(HIF)稳定剂属于一类新型的具有药理活性的物质,能够诱导内源性红细胞生成系统。转录激活因子 HIF 已被证明能显著增加血液血红蛋白,非常适合治疗慢性肾病引起的贫血。本研究全面研究了口服罗沙司他及其代谢物在纯种马尿液中的情况。使用液质联用技术推测了所检测到的代谢物的可能结构。在实验条件下,共检测到 13 种代谢物(7 种 I 相代谢物、1 种 II 相代谢物和 5 种 I 相代谢物的结合物)(M1-M13)。鉴定的主要 I 相代谢物是通过羟化形成的。本研究还观察到脱烷基和水解的 I 相代谢物。在 II 相中,检测到罗沙司他的葡萄糖醛酸缀合物为主要代谢物。观察到磺酸缀合物是由 I 相代谢物形成的。所鉴定的体内代谢物可能作为兴奋剂控制分析的靶标分析物;因此,该结果是评估其在竞技体育中使用和滥用的重要工具。

相似文献

1
Identification of Hypoxia-inducible factor (HIF) stabilizer roxadustat and its possible metabolites in thoroughbred horses for doping control.用于兴奋剂控制的促红细胞生成素稳定剂罗沙司他及其可能代谢物在纯种马中的鉴定。
Drug Test Anal. 2021 Jun;13(6):1203-1215. doi: 10.1002/dta.3014. Epub 2021 Feb 23.
2
Investigation of the metabolites of the HIF stabilizer FG-4592 (roxadustat) in five different in vitro models and in a human doping control sample using high resolution mass spectrometry.使用高分辨率质谱法在五种不同的体外模型和一份人体兴奋剂对照样品中对低氧诱导因子稳定剂FG-4592(罗沙司他)的代谢产物进行研究。
J Pharm Biomed Anal. 2017 Feb 5;134:228-236. doi: 10.1016/j.jpba.2016.11.041. Epub 2016 Nov 27.
3
Metabolic studies of hypoxia-inducible factor stabilisers IOX2, IOX3 and IOX4 (in vitro) for doping control.缺氧诱导因子稳定剂 IOX2、IOX3 和 IOX4 的代谢研究(体外)用于兴奋剂控制。
Drug Test Anal. 2021 Apr;13(4):794-816. doi: 10.1002/dta.3000. Epub 2021 Feb 9.
4
Development of liquid chromatography-tandem mass spectrometry-based analytical assays for the determination of HIF stabilizers in preventive doping research.开发基于液相色谱-串联质谱的分析方法,用于在预防兴奋剂研究中测定 HIF 稳定剂。
Drug Test Anal. 2011 Nov-Dec;3(11-12):756-70. doi: 10.1002/dta.365.
5
Implementation of the HIF activator IOX-2 in routine doping controls - Pilot study data.HIF 激活剂 IOX-2 在常规兴奋剂检测中的实施——初步研究数据。
Drug Test Anal. 2020 Nov;12(11-12):1614-1619. doi: 10.1002/dta.2914. Epub 2020 Sep 1.
6
lmplementation of the prolyl hydroxylase inhibitor Roxadustat (FG-4592) and its main metabolites into routine doping controls.脯氨酰羟化酶抑制剂罗沙司他(FG-4592)及其主要代谢产物在常规兴奋剂检测中的应用。 (注:原文中“lmplementation”拼写错误,应为“Implementation”)
Drug Test Anal. 2017 Nov;9(11-12):1768-1778. doi: 10.1002/dta.2202. Epub 2017 May 31.
7
Detection by LC-MS/MS of HIF stabilizer FG-4592 used as a new doping agent: Investigation on a positive case.采用液相色谱-串联质谱法检测用作新型兴奋剂的低氧诱导因子稳定剂FG-4592:对一例阳性案例的调查
J Pharm Biomed Anal. 2016 Mar 20;121:181-187. doi: 10.1016/j.jpba.2016.01.029. Epub 2016 Jan 15.
8
Detection of FG-4592 and metabolites in equine plasma, urine and hair following oral administration.口服 FG-4592 及其代谢物在马血浆、尿液和毛发中的检测。
Drug Test Anal. 2024 Oct;16(10):1167-1181. doi: 10.1002/dta.3643. Epub 2024 Jan 12.
9
Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls.脯氨酰羟化酶抑制剂GSK1278863、其二羟基化代谢物的质谱表征及其在常规兴奋剂检测中的应用。
Drug Test Anal. 2016 Aug;8(8):858-63. doi: 10.1002/dta.1870. Epub 2015 Sep 11.
10
Metabolic study of selective androgen receptor modulator LY2452473 in thoroughbred horses for doping control.用于兴奋剂检测的纯种马中选择性雄激素受体调节剂LY2452473的代谢研究。
Rapid Commun Mass Spectrom. 2023 May 15;37(9):e9491. doi: 10.1002/rcm.9491.

引用本文的文献

1
Bioanalysis, Analysis, Chemistry, and Pharmacological Aspects of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors.缺氧诱导因子脯氨酰羟化酶抑制剂的生物分析、分析、化学及药理学方面
Curr Top Med Chem. 2025;25(12):1451-1466. doi: 10.2174/0115680266324419241227102847.
2
A critical review of Roxadustat formulations, solid state studies, and analytical methodology.罗沙司他制剂、固态研究及分析方法的批判性综述。
Heliyon. 2023 Jun 1;9(6):e16595. doi: 10.1016/j.heliyon.2023.e16595. eCollection 2023 Jun.
3
Pharmacokinetic Study of Vadadustat and High-Resolution Mass Spectrometric Characterization of its Novel Metabolites in Equines for the Purpose of Doping Control.
在赛马兴奋剂控制目的下,对vadadustat 的药代动力学研究及其在马属动物中新型代谢物的高分辨质谱特征分析。
Curr Drug Metab. 2022;23(10):850-865. doi: 10.2174/1389200223666220825093945.